Ara T, et al. Determination of imbalance between MMP-2 and TIMP-2 in human neuroblastoma by reverse-transcription polymerase chain reaction and its correlation with tumor progression. J Pediatr Surg. 2000 Mar;35(3):432-7.
[Related articles] |
Arihara Z, et al. Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma. Peptides. 2000 Apr 1;21(4):565-570.
[Related articles] |
Bieberich E, et al. Effect of N-glycosylation on turnover and subcellular distribution of N-acetylgalactosaminyltransferase I and sialyltransferase II in neuroblastoma cells. J Neurochem. 2000 Jun;74(6):2359-64.
[Related articles] |
Cho HS, et al. Retroviral-mediated IL-2 gene transfer into murine neuroblastoma. Yonsei Med J. 2000 Feb;41(1):76-81.
[Related articles] |
Cinatl J Jr, et al. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs. Anticancer Res. 2000 Mar-Apr;20(2A):853-9.
[Related articles] |
Eggert A, et al. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene. 2000 Apr 13;19(16):2043-51.
[Related articles] |
Grotzer MA, et al. Biological stability of RNA isolated from RNAlater-treated brain tumor and neuroblastoma xenografts. Med Pediatr Oncol. 2000 Jun;34(6):438-442.
[Related articles] |
Handler A, et al. Functional implications of the noradrenergic-cholinergic switch induced by retinoic acid in NB69 neuroblastoma cells. J Neurosci Res. 2000 May 1;60(3):311-20.
[Related articles] |
Hoy A, et al. Effect of apolipoprotein E on cell viability in a human neuroblastoma cell line: influence of oxidation and lipid-association. Neurosci Lett. 2000 May 19;285(3):173-6.
[Related articles] |
Iolascon A, et al. Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas. Br J Cancer. 2000 Mar;82(6):1171-6.
[Related articles] |
Langer I, et al. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas. Med Pediatr Oncol. 2000 Jun;34(6):386-393.
[Related articles] |
Matsuo T, et al. Structure and Promoter Analysis of the Human unc-33-like Phosphoprotein Gene. E-BOX required for maximal expression in neuroblastoma and myoblasts. J Biol Chem. 2000 May 26;275(22):16560-16568.
[Related articles] |
Raghunath M, et al. A novel kinase, AATYK induces and promotes neuronal differentiation in a human neuroblastoma (SH-SY5Y) cell line. Brain Res Mol Brain Res. 2000 May 5;77(2):151-162.
[Related articles] |
Schaefer JT, et al. Ceramide induces apoptosis in neuroblastoma cell cultures resistant to CD95 (Fas/APO-1)-mediated apoptosis. J Pediatr Surg. 2000 Mar;35(3):473-9.
[Related articles] |
Seidel B, et al. Differentially displayed genes in neuroblastoma cells treated with a mitochondrial toxin: evidence for possible involvement of ICAM-1 in 3-nitropropionic acid-mediated neurodegeneration. Toxicol Lett. 2000 Jun 5;115(3):213-222.
[Related articles] |
Shimono R, et al. The expression of cadherins in human neuroblastoma cell lines and clinical tumors. Anticancer Res. 2000 Mar-Apr;20(2A):917-23.
[Related articles] |
Teitz T, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med. 2000 May;6(5):529-35.
[Related articles] MYCN Amplification
|
Tindberg N, et al. Contribution of MAP kinase pathways to the activation of ATF-2 in human neuroblastoma cells. Neurochem Res. 2000 Apr;25(4):527-31.
[Related articles] |